Molecular analysis of 289 chromosomes has been performed in a cohort of phenylketonuria (PKU) patients whose ancestors lived in five Italian regions, Calabria, Campania, Piemonte, Puglia/Basilicata and Sicilia. Phenylalaninehydroxylase (PAH) gene mutations and minihaplotypes (combinations of PAH gene STR and VNTR systems) have been determined for 78.5 and 64%, respectively, of the chromosomes studied. 21 different minihaplotypes and 24 PKU mutations were found. Heterogeneity tests carried out for the frequencies of mutations and minihaplotypes show that the distribution of eight mutations and four minihaplotypes is statistically heterogeneous in the five Italian regions. Although the evolutionary rate of microsatellites or the age of these mutations is difficult to estimate with accuracy, our findings taken together show a genetic stratification of the Italian population. These results rule out allelic homogeneity of PKU at the molecular level between regions of Italy, yet minihaplotype data may be of practical use for a multistep approach to PAH gene genotyping.

1.
Scriver CR, Kaufman S, Eisensmith RC, Woo SCL: The hyperphenylalaninemias; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease, ed 7. New York, McGraw-Hill, 1995, pp 1015–1075.
2.
Eisensmith RC, Woo SLC: Molecular genetics of phenylketonuria: From molecular anthropology to gene therapy. Adv Genet 1995;32:199–271.
3.
Nowacki PM, Byck S, Prevost L, Scriver CR: PAH Mutation Analysis Consortium Database: 1997. Prototype for relational locus-specific mutation databases. Nucleic Acids Res 1998;26:220–225.
4.
DiLella AG, Kwoc SCM, Leedley FD, Marvit J, Woo SLC: Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene. Biochemistry 1986;25:743–749.
5.
Eisensmith RC, Woo SLC: Updated listing of haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet 1992;51:1445–1448.
6.
Goltsov AA, Eisensmith RC, Naughten ER, Woo SLC: A single polymorphic STR system in the human phenylalanine hydroxylase gene permits rapid prenatal diagnosis and carrier screening for phenylketonuria. Hum Mol Genet 1993;2:577–581.
7.
Goltsov AA, Eisensmith RC, Konecki DS, Lichter-Konecki U, Woo SLC: Linkage disequilibrium between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am J Hum Genet 1992;51:627–636.
8.
Byck S, Morgan K, Tyfield L, Dworniczak B, Scriver CR: Evidence for origin, by recurrent mutation, of the phenylalanine hydroxylase R408W mutation on two haplotypes in European and Quebec populations. Hum Mol Genet 1994;3:1675–1677.
9.
Scriver CR, Byck S, Prevost L, Hoang L and the PAH Mutation Analysis Consortium: The phenylalanine hydroxylase locus: A marker for the history of phenylketonuria and human genetic diversity. Variation in the human genome. Ciba Foundation Symposium 197, Chichester, Wiley, 1996, pp 73–96.
10.
Guldberg P, Henriksen KF, Güttler F: Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 1993;17:141–146.
11.
Dianzani I, Giannattasio S, de Sanctis L, Alliaudi C, Lattanzio P, Dionisi Vici C, Burlina A, Burroni M, Sebastio G, Carnevale F, Guzzetta V, Marra E, Camaschella C, Ponzone A: Characterization of phenylketonuria alleles in the Italian population. Eur J Hum Genet 1995;3:294–302.
12.
Dianzani I, Devoto M, Camaschella C, Saglio G, Ferrero GB, Cerone R, Romano C, Romeo G, Giovannini M, Riva E, Angeneydt F, Trefz FK, Okano Y, Woo SLC: Haplotype distribution and molecular defects at the phenylalanine hydroxylase locus in Italy. Hum Genet 1990;86:69–72.
13.
Peréz B, Desviat LR, and Ugarte M: Analysis of the phenylalanine hydroxylase gene in the Spanish population: Mutation profile and association with intragenic polymorphic markers. Am J Hum Genet 1997;60:95–102.
14.
Dianzani I, Giannattasio S, de Sanctis L, Marra E, Ponzone A, Camaschella C, Piazza A: Genetic history of phenylketonuria mutations in Italy. Am J Hum Genet 1994;55:851–853.
15.
Rendine S, Calafell F, Cappello N, Gagliardini R, Caramia G, Rigillo N, Silvetti M, Zanda M, Miano A, Battistini F, Marianelli L, Taccetti G, Diana MC, Romano L, Romano C, Giunta A, Padoan R, Pianaroli A, Raia V, De Ritis G, Battistini A, Grzincich G, Japichino L, Pardo F, Antonelli M, Quattrucci S, Lucidi V, Castro M, Santini B, Castello M, Guanti G, Leoni GB, Cao A, Toffoli C, Lucci E, Vullo C, Torricelli F, Sbernini F, Romeo G, Ronchetto P, Seia M, Rossi A, Ferrari M, Cremonesi L, Salvatore F, Castaldo G, D’Alcamo E, Maggio A, Sangiuolo F, Dallapiccola B, Maceratesi P, Bisceglia L, Gasparini P, Carbonara A, Bonizzato A, Cabrini G, Bombieri C, Pignatti PF, Borgo G, Castellani C, Villani A, Arduino C, Salvatore D, Mastella G, Piazza A: Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution. Ann Hum Genet 1997;61:411–424.
16.
Calì F, Dianzani I, Desviat LR, Perez B, Ugarte M, Ozguc M, Seyrantepe V, Shiloh Y, Giannattasio S, Carducci C, Bosco P, De Leo G, Piazza A, Romano V: The STR252-IVS10nt546-vntr7 phenylalanine hydroxylase minihaplotype in five Mediterranean samples. Hum Genet 1997;100:350–355.
17.
Eisensmith RC, Okano Y, Dasovich M, Wang T, Güttler F, Lou H, Guldberg P, Lichter-Konecki U, Konecki DS, Svensson E, Hagenfeldt L, Rey F, Munnich A, Lyonnet S, Cockburn F, Conor JM, Pembrey ME, Smith I, Gitzelmann R, Steinmann B, Apold J, Eiken HG, Giovannini M, Riva E, Longhi C, Romano V, Cerone R, Naughten ER, Mullins C, Cahalane S, Ozalp I, Fekete G, Schuler D, Berencsi GY, Nasz I, Brdicka R, Kamarit J, Pijackova A, Cabalska B, Boszkova K, Schwartz E, Kalinin VN, Jin L, Chakraborty R, Woo SLC: Multiple origins for phenylketonuria in Europe. Am J Hum Genet 1992;51:1355–1365.
18.
Zschocke J, Hoffmann GF: Phenylketonuria mutations in Germany. Hum Genet 1999;104:390–398.
19.
Dianzani I, Camaschella C, Ponzone A, Cotton RG: Dilemmas and progress in mutation detection. Trends Genet 1993;9:403–405.
20.
Guldberg P, Romano V, Ceratto N, Bosco P, Ciuna M, Indelicato A, Mollica F, Meli C, Giovannini M, Riva E, Biasucci G, Henrikesen F, Güttler F: Mutational spectrum of phenylalanine hydroxylase deficiency in Sicilia: Implications for diagnosis of hyperphenylalaninemia in southern Europe. Hum Mol Genet 1993;2:1703–1707.
21.
Giannattasio S, Bisceglia L, Lattanzio P, Grifa A, Dianzani I, Gasparini P, Marra E: Molecular screening of genetic defects with RNA-SSCP analysis: The PKU and cystinuria model. Mol Cell Probes 1995;9:201–205.
22.
Guzzetta V, Bonapace G, Dianzani I, Parenti G, Lecora M, Giannattasio S, Concolino D, Strisciuglio P, Sebastio G, Andria G: Phenylketonuria in Italy: Distinct distribution pattern of three mutations of the phenylalanine hydroxylase gene. J Inher Metab Dis 1997;20:619–624.
23.
Bobba A, Iolascon A, Giannattasio S, Albrizio M, Sinisi A, Prisco F, Schettini F, Marra E: Characterization of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene. J Med Genet 1997;34:223–228.
24.
Giannattasio S, Lattanzio P, Bobba A, Marra E: Detection of microsatellites by ethidium bromide staining. The analysis of the STR system in the human phenylalanine hydroxylase gene. Mol Cell Probes 1996;11:81–83.
25.
Zschocke J, Graham CA, McKnight JJ, Nevin NC: The STR system in the human phenylalanine hydroxylase gene: True fragment length obtained with fluorescent labelled PCR primers. Acta Pediatr Suppl 1994;407:41–42.
26.
Zschocke J, Graham CA, Carson DJ, Nevin NC: Phenylketonuria mutation analysis in Northern Ireland: A rapid stepwise approach. Am J Hum Genet 1995;57:1311–1317.
27.
Ramus SJ, Treacy EP, Cotton RGH: Characterization of phenylalanine hydroxylase alleles in untreated phenylketonuria patients from Victoria, Australia: Origin of alleles and haplotypes. Am J Hum Genet 1995;56:1034–1041.
28.
Cooper DN, Youssoufian H: The CpG dinucleotide and human genetic disease. Hum Genet 1998;78:151–155.
29.
Piazza A, Cappello N, Olivetti E, Rendine S: A genetic history of Italy. Ann Hum Genet 1988;52:203–213.
30.
Kayaalp E, Treacy E, Waters PJ, Byck S, Nowacki P, Scriver CR: Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes. A metanalysis of genotype-phenotype correlations. Am J Hum Genet 1997;61:1309–1317.
31.
Guldberg P, Rey F, Zschocke J, Romano V, François B, Michiels L, Ullrich K, Hoffmann GF, Burgard P, Schmidt H, Meli C, Riva E, Dianzani I, Ponzone A, Rey JG, Güttler F: A European multicenter study of phenylalanine hydroxylase deficiency: Classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 1998;63:71–79.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.